The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
Abstract
Background: Clinical predictors of advanced non-alcoholic liver disease (NAFLD) are needed to guide diagnostic evaluation and treatment. Methods: To better understand the demographics of NAFLD and risk factors for advanced disease, this study analysed 827 patients with NAFLD at two geographically separate tertiary medical centres. Results: The cohort was 51% female and had a median body mass index (BMI) of 33 kg/m 2 ; 3% had a normal BMI. Common co-morbidities included hypertension (60%) and diabetes (35%); insulin resistance was present in 91% and advanced fibrosis in 24% of patients. When comparing patients with no fibrosis or mild fibrosis to those with advanced fibrosis, BMI ⩾28 kg/m 2 , age >50 years, and aspartate transaminase/alanine aminotransferase (AST/ALT) ratio ⩾0.8, a quantitative assessment check index (QUICKI) score <0.294 (equivalent to homeostatasis model assessment (HOMA) >6.2) and the presence of diabetes mellitus (DM) were individually associated by univariate analysis with odds ratios (ORs) of ⩾2.4 for advanced fibrosis. Based on the results of forced entry logistic regression analysis, three variables were combined in a weighted sum ( B MI ⩾28 = 1 point, A AR of ⩾0.8 = 2 points, D M = 1 point) to form an easily calculated composite score for predicting advanced fibrosis called the BARD score. A score of 2–4 was associated with an OR for advanced fibrosis of 17 (confidence interval 9.2 to 31.9) and a negative predictive value of 96%. Conclusions: Insulin resistance and its co-morbidities are often present in patients with NAFLD. An easily calculated score based on readily available clinical data can reliably exclude the presence of advanced fibrosis in these patients, particularly among non-diabetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Self-citationPrevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Self-citationLiver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Adams, L. A., Sanderson, S., Lindor, K. D., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.012 · Cited by 911
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
Marceau, P. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1513 · Cited by 635
Hepatic histology in obese patients undergoing bariatric surgery
Machado, M., Marques-Vidal, P., & Cortez-Pinto, H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.013 · Cited by 583
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Self-citationNatural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440
Willner, I. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)03229-4 · Cited by 420
Mather, K. J., Hunt, A. E., Steinberg, H. O., Paradisi, G., Hook, G., Katz, A., Quon, M. J., & Baron, A. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7880 · Cited by 363
Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients
Ong, J. P., Elariny, H., Collantes, R., Younoszai, A., Chandhoke, V., Reines, H. D., Goodman, Z., & Younossi, Z. M. (2005) · Obesity Surgery · doi:10.1381/0960892053576820 · Cited by 322
Skelly, M. M., James, P. D., & Ryder, S. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00094-0 · Cited by 310
Hřebíček, J., Janout, V., Malinčíková, J., Horáková, D., & Čížek, L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8292 · Cited by 284
FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE
LEEVY, C. M. (1962) · Medicine · doi:10.1097/00005792-196209000-00003 · Cited by 272
Garcia-Monzón, C., Martín-Pérez, E., Iacono, O. L., Fernández-Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E., & Moreno-Otero, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80301-3 · Cited by 265
REVIEW: Nonalcoholic steatohepatitis
LUDWIG, J., McGILL, D. B., & LINDOR, K. D. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00450.x · Cited by 248
Chitturi, S., Weltman, M., Farrell, G. C., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33892 · Cited by 247
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00029 · Cited by 243
Pinto, H. C., Baptista, A., Camilo, M. E., Valente, A., Saragoça, A., & de Moura, M. C. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02208601 · Cited by 219
Is Liver Biopsy Useful in the Evaluation of Patients with Chronically Elevated Liver Enzymes?
Van Ness, M. M., & Diehl, A. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-6-473 · Cited by 213
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
Angulo, P., Alba, L. M., Petrovic, L. M., Adams, L. A., Lindor, K. D., & Jensen, M. D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.020 · Cited by 197
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
Choudhury, J., & Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.006 · Cited by 177
Natural History of NAFLD: Remarkably Benign in the Absence of Cirrhosis
Day, C. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.041 · Cited by 176
Hepatic steatosis and insulin resistance: Does etiology make a difference?
Lonardo, A., Lombardini, S., Scaglioni, F., Carulli, L., Ricchi, M., Ganazzi, D., Adinolfi, L. E., Ruggiero, G., Carulli, N., & Loria, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.018 · Cited by 159
Mathiesen, U. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950172880 · Cited by 150
Hrebicek, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.144 · Cited by 146
Hay, E. J., Czaja, A. J., Rakela, J., & Ludwig, J. (1989) · Hepatology · doi:10.1002/hep.1840090205 · Cited by 145
Berasain, C., Betés, M., Panizo, A., Ruiz, J., Herrero, J. I., Civeira, M.-P., & Prieto, J. (2000) · Gut · doi:10.1136/gut.47.3.429 · Cited by 131
Tarugi, P., Lonardo, A., Ballarini, G., Grisendi, A., Pulvirenti, M., Bagni, A., & Calandra, S. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70082-3 · Cited by 102
Ryan, M. C., Wilson, A., Slavin, J., Best, J. D., Jenkins, A. J., & Desmond, P. V. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1222 · Cited by 100
Papadia, F. S., Marinari, G. M., Camerini, G. B., Murelli, F., Carlini, F., Stabilini, C., & Scopinaro, N. (2004) · Obesity Surgery · doi:10.1381/0960892041719644 · Cited by 78
Prevalence of Non-alcoholic Steatohepatitis in Morbidly Obese Subjects Undergoing Gastric Bypass
Spaulding, L., Trainer, T. D., & Janiec, D. J. (2003) · Obesity Surgery · doi:10.1381/096089203765887633 · Cited by 77
Lainé, F., Bendavid, C., Moirand, R., Tessier, S., Perrin, M., Guillygomarc’h, A., Guyader, D., Calon, E., Renault, A., Brissot, P., et al. (2004) · Hepatology · doi:10.1002/hep.20219 · Cited by 66
Fatty liver due to heterozygous hypobetalipoproteinemia.
Wishingrad, M., Paaso, B., & García, G. (1994) · PubMed · Cited by 25
Cited by
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Shah, A. G., Lydecker, A., Murray, K., Tetri, B. N., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,553
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Metadata
- Authors
- Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2008-04-04
- Volume
- 57
- Issue
- 10
- Pages
- 1441-1447
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2171172585
- Cited by
- 869
- References
- 46
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.